Mirogabalin: Mirogabalin is approved in Japan and several Asian countries for diabetic peripheral neuropathic pain and postherpetic neuralgia. It has higher binding affinity and slower dissociation from α2δ-1 subunits compared to pregabalin, potentially offering improved analgesic effects with fewer
Related pages